10x Genomics annual revenue
2017
2018
2019
2020
2021
2022
2023
2024
2025
10x Genomics Revenue Growth & History (TXG)
10x Genomics reported $642.8M in revenue for fiscal 2025, an increase of 5.25% from the previous fiscal year.
View full 10x Genomics company overview10x Genomics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $642.8M | $32.0M | +5.25% |
| 2024 | 2024-12-31 | $610.8M | −$7.9M | −1.28% |
| 2023 | 2023-12-31 | $618.7M | $102.3M | +19.81% |
| 2022 | 2022-12-31 | $516.4M | $25.9M | +5.28% |
| 2021 | 2021-12-31 | $490.5M | $191.6M | +64.13% |
| 2020 | 2020-12-31 | $298.8M | $53.0M | +21.53% |
| 2019 | 2019-12-31 | $245.9M | $99.6M | +68.06% |
| 2018 | 2018-12-31 | $146.3M | $75.2M | +105.83% |
| 2017 | 2017-12-31 | $71.1M | — | — |
10x Genomics quarterly revenue
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $151.0M | −$21.9M | −12.65% |
| Q1 2026 | 2026-03-31 | $150.8M | −$4.0M | −2.61% |
| Q4 2025 | 2025-12-31 | $166.0M | $1.0M | +0.61% |
| Q3 2025 | 2025-09-30 | $149.0M | −$2.7M | −1.75% |
| Q2 2025 | 2025-06-30 | $172.9M | $19.8M | +12.93% |
| Q1 2025 | 2025-03-31 | $154.9M | $13.9M | +9.84% |
| Q4 2024 | 2024-12-31 | $165.0M | −$19.0M | −10.30% |
| Q3 2024 | 2024-09-30 | $151.7M | −$2.0M | −1.30% |
| Q2 2024 | 2024-06-30 | $153.1M | $6.3M | +4.28% |
| Q1 2024 | 2024-03-31 | $141.0M | $6.7M | +5.01% |
| Q4 2023 | 2023-12-31 | $184.0M | $27.7M | +17.76% |
| Q3 2023 | 2023-09-30 | $153.6M | $22.6M | +17.22% |
| Q2 2023 | 2023-06-30 | $146.8M | $32.2M | +28.10% |
| Q1 2023 | 2023-03-31 | $134.3M | $19.8M | +17.28% |
| Q4 2022 | 2022-12-31 | $156.2M | $12.7M | +8.85% |
| Q3 2022 | 2022-09-30 | $131.1M | $5.8M | +4.61% |
| Q2 2022 | 2022-06-30 | $114.6M | −$1.2M | −1.06% |
| Q1 2022 | 2022-03-31 | $114.5M | $8.7M | +8.20% |
| Q4 2021 | 2021-12-31 | $143.5M | $31.3M | +27.90% |
| Q3 2021 | 2021-09-30 | $125.3M | $53.5M | +74.47% |
| Q2 2021 | 2021-06-30 | $115.8M | $72.9M | +170.00% |
| Q1 2021 | 2021-03-31 | $105.8M | $33.9M | +47.17% |
| Q4 2020 | 2020-12-31 | $112.2M | $36.9M | +49.05% |
| Q3 2020 | 2020-09-30 | $71.8M | $10.6M | +17.33% |
| Q2 2020 | 2020-06-30 | $42.9M | −$12.9M | −23.14% |
| Q1 2020 | 2020-03-31 | $71.9M | $18.3M | +34.21% |
| Q4 2019 | 2019-12-31 | $75.3M | $24.7M | +48.93% |
| Q3 2019 | 2019-09-30 | $61.2M | $24.6M | +67.20% |
| Q2 2019 | 2019-06-30 | $55.8M | $24.1M | +75.84% |
| Q1 2019 | 2019-03-31 | $53.6M | $26.2M | +95.48% |
| Q4 2018 | 2018-12-31 | $50.6M | — | — |
| Q3 2018 | 2018-09-30 | $36.6M | — | — |
| Q2 2018 | 2018-06-30 | $31.7M | — | — |
| Q1 2018 | 2018-03-31 | $27.4M | — | — |
10x Genomics revenue growth trends
Over the last five reported fiscal years, revenue grew from $298.8M to $642.8M, a compound annual growth rate of 16.55%. 10x Genomics's latest reported quarter, Q2 2026, generated $151.0M in revenue, a decrease of 12.65% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review 10x Genomics source filings ↗